Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 4/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.64 |
| ▸ | HPGD | P15428 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.64 |
| ▸ | MEN1 | O00255 | 3/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | USP2 | O75604 | 2/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | TP53 | P04637 | 2/20 | 0.64 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.64 |
| ▸ | HTT | P42858 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | EGFR | P00533 | 1/20 | 0.64 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.64 |
| ▸ | LCK | P06239 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 8-Hydroxy-7-Iodo-5-Quinolinesulfonic Acid SCHEMBL29385217 | 0.88 | HIF1A (0.64) | HIF1AALOX15HPGDALDH1A1HSP90AA1 | |
| 8-Hydroxy-7-Iodo-5-Quinolinesulfonic Acid SCHEMBL94250 | 0.88 | HIF1A (0.64) | HIF1AALOX15HPGDALDH1A1HSP90AA1 | |
| 8-Hydroxy-7-Iodo-5-Quinolinesulfonic Acid SCHEMBL8140547 | 0.87 | HIF1A (0.62) | HIF1AALOX15HPGDALDH1A1HSP90AA1 | |
| SCHEMBL4461500 | 0.86 | COMT (0.64) | HIF1AALOX15HPGDALDH1A1HSP90AA1 | |
| 8-Hydroxy-7-Iodo-5-Quinolinesulfonic Acid SCHEMBL27581572 | 0.85 | HIF1A (0.56) | HIF1AALOX15HPGDALDH1A1HSP90AA1 | |
| SCHEMBL11458790 | 0.83 | COMT (0.56) | HIF1AALOX15HPGDALDH1A1HSP90AA1 | |
| SCHEMBL10908982 | 0.82 | MEN1 (0.64) | HIF1AALOX15HPGDALDH1A1HSP90AA1 | |
| SCHEMBL12192929 | 0.82 | HSP90AA1 (0.69) | HIF1AALOX15HPGDALDH1A1HSP90AA1 | |
| 8-Hydroxy-7-Iodo-5-Quinolinesulfonic Acid SCHEMBL4459429 | 0.81 | HIF1A (0.55) | HIF1AALOX15HPGDALDH1A1HSP90AA1 | |
| SCHEMBL13921640 | 0.79 | COMT (0.66) | HIF1AALOX15HPGDALDH1A1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10729630-B2 | Shaping keratin fibres using an active agent comprising at least two functional groups selected from: —C(OH)- and —C(=O)OH | THE PROCTER & GAMBLE COMPANY (US) | 2020-08-04 | — | — | US | claimed |
| CN-105828786-B | Shaping keratin fibres using AN AN active agent comprising a functional group selected from-C (═ O) -, -C (═ O) -H and-C (═ O) -O-) | 宝洁公司 | 2020-07-07 | — | — | CN | claimed |
| EP-3082494-B1 | METHOD FOR SHAPING FIBROUS MATERIAL | PROCTER & GAMBLE (US) | 2018-12-05 | — | — | EP | claimed |
| EP-3082746-B1 | SHAPING KERATIN FIBRES USING AN AMINE OR A DIAMINE | PROCTER & GAMBLE (US) | 2018-11-28 | — | — | EP | claimed |
| EP-3082736-B1 | SHAPING KERATIN FIBRES USING 2-HYDROXYPROPANE-1,2,3-TRICARBOXYLIC ACID AND/OR 1,2,3,4-BUTANETETRACARBOXYLIC ACID | PROCTER & GAMBLE (US) | 2018-08-08 | — | — | EP | claimed |
| EP-3082747-B1 | SHAPING KERATIN FIBRES USING A SUGAR | PROCTER & GAMBLE (US) | 2018-07-04 | — | — | EP | claimed |
| EP-3082731-B1 | SHAPING KERATIN FIBRES USING AN ACTIVE AGENT COMPRISING AT LEAST TWO FUNCTIONAL GROUPS SELECTED FROM: -C(OH)- AND -C(=O)OH | PROCTER & GAMBLE (US) | 2018-07-04 | — | — | EP | claimed |
| EP-3082735-B1 | SHAPING KERATIN FIBRES USING OXOETHANOIC ACID AND/OR DERIVATIVES THEREOF | PROCTER & GAMBLE (US) | 2018-05-02 | — | — | EP | claimed |
| US-9918921-B2 | Methods for shaping fibrous material and treatment compositions therefor | THE PROCTER & GAMBLE COMPANY (US) | 2018-03-20 | — | — | US | claimed |
| US-9877559-B2 | Methods for shaping fibrous material and treatment compositions therefor | THE PROCTER & GAMBLE COMANY (US) | 2018-01-30 | — | — | US | claimed |
| WO-2015094756-A1 | SHAPING KERATIN FIBRES USING AN AMINE OR A DIAMINE | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-25 | — | — | WO | claimed |
| WO-2015094789-A1 | METHODS FOR SHAPING FIBROUS MATERIAL AND TREATMENT COMPOSITIONS THEREFOR | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-25 | — | — | WO | claimed |
| WO-2015094757-A1 | SHAPING KERATIN FIBRES USING A SUGAR | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-25 | — | — | WO | claimed |
| WO-2015095671-A1 | SHAPING KERATIN FIBRES USING OXOETHANOIC ACID AND/OR DERIVATIVES THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-25 | — | — | WO | claimed |
| US-20150174029-A1 | SHAPING KERATIN FIBRES USING AN ACTIVE AGENT COMPRISING AT LEAST TWO FUNCTIONAL GROUPS SELECTED FROM: -C(OH)- AND -C(=O)OH | THE PROCTER & GAMBLE COMPANY | 2015-06-25 | — | — | US | claimed |
| WO-2015094790-A1 | METHODS FOR SHAPING FIBROUS MATERIAL AND TREATMENT COMPOSITIONS THEREFOR | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-25 | — | — | WO | claimed |
| WO-2015094784-A1 | METHODS FOR SHAPING FIBROUS MATERIAL AND TREATMENT COMPOSITIONS THEREFOR | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-25 | — | — | WO | claimed |
| US-20150173478-A1 | Methods for Shaping Fibrous Material and Treatment Compositions Therefor | THE PROCTER & GAMBLE COMPANY | 2015-06-25 | — | — | US | claimed |
| WO-2015095685-A1 | SHAPING KERATIN FIBRES USING 2-HYDROXYPROPANE-1,2,3-TRICARBOXYLIC ACID AND/OR 1,2,3,4-BUTANETETRACARBOXYLIC ACID | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-25 | — | — | WO | claimed |
| WO-2015094788-A1 | METHODS FOR SHAPING FIBROUS MATERIAL AND TREATMENT COMPOSITIONS THEREFOR | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150174029-A1 | SHAPING KERATIN FIBRES USING AN ACTIVE AGENT COMPRISING AT LEAST TWO FUNCTIONAL GROUPS SELECTED FROM: -C(OH)- AND -C(=O)OH | KRT18, CKAP4, JUP | HIF1A 2950/4885ALOX15 4180/4885HPGD 2441/4885 |
| US-10729630-B2 | Shaping keratin fibres using an active agent comprising at least two functional groups selected from: —C(OH)- and —C(=O)OH | KRT18, CKAP4, JUP | HIF1A 2891/4885ALOX15 4207/4885HPGD 2270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.